MEDCOMMERCE Trademark

Trademark Overview

On Thursday, September 14, 2023, a trademark application was filed for MEDCOMMERCE with the United States Patent and Trademark Office. The USPTO has given the MEDCOMMERCE trademark a serial number of 98975644. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, August 21, 2024. This trademark is owned by REPEATMD, INC.. The MEDCOMMERCE trademark is filed in the Insurance & Financial Services category with the following description:

Financing services
medcommerce

General Information

Serial Number98975644
Word MarkMEDCOMMERCE
Filing DateThursday, September 14, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkMEDICAL COMMERCE
Pseudo MarkMED COMMERCE
Goods and ServicesFinancing services

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 14, 2023
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREPEATMD, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77056

Trademark Events

Event DateEvent Description
Thursday, September 14, 2023NEW APPLICATION ENTERED
Wednesday, November 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 8, 2024ASSIGNED TO EXAMINER
Tuesday, May 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2024NON-FINAL ACTION E-MAILED
Tuesday, May 21, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, July 16, 2024AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, July 16, 2024USE AMENDMENT FILED
Wednesday, July 24, 2024USE AMENDMENT ACCEPTED
Wednesday, August 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 21, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, August 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, February 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 3, 2025DIVISIONAL PROCESSING COMPLETE

Related Keywords

medcommerce services financing